Immediate analgesic effect of acupuncture for acute primary dysmenorrhea: protocol of a randomized controlled trial

针灸治疗急性原发性痛经的即时镇痛效果:一项随机对照试验方案

阅读:2

Abstract

BACKGROUND: Primary dysmenorrhea (PD) is a common gynecological disorder that significantly affects women's work and personal lives, especially in acute episodes when immediate pain relief is often needed. The objective of this study is to evaluate the immediate analgesic effect of acupuncture for acute PD within 10 min. METHODS: This is a randomized sham-controlled clinical trial involving 80 participants with acute PD who will be randomized in a 1:1 ratio into the Acupuncture group and the Sham acupuncture group. Each participant will receive 10 min acupuncture session. For participants in the Sham acupuncture (SA) group, the Park Sham Acupuncture Device (PSD) and blunt needles will be used to simulate treatment without skin penetration. The visual analog scale (VAS) will be evaluated before treatment and at 0-1, 2, 4, 6, 8, and 10 min after treatment. The primary outcome is the effective analgesia rate after 10 min of acupuncture. Secondary outcomes include effective analgesia rate at other time points (0-1, 2, 4, 6, and 8 min), VAS, blinding assessment, and the treatment effectiveness expectations scale. Adverse events during each treatment period will be collected and recorded. All outcomes will be analyzed on an intention-to-treat. The recruitment for this study is expected to be completed between May 1, 2024, and September 1, 2025. DISCUSSION: The primary need of patients with PD is the immediate relief of pain. This study aims to investigate the immediate analgesic effect of acupuncture on acute PD. The results of this study will provide a rapid and reliable clinical basis for the use of acupuncture in the treatment of PD, potentially offering a non-pharmacological alternative for pain management that could reduce reliance on medications and their associated side effects. CLINICAL TRIAL REGISTRATION: Identifier ChiCTR2300070826. This study has been registered at the Chinese Clinical Trial Registry (https://www.chictr.org.cn).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。